Sid blood group system

From WikiMD's WELLNESSPEDIA

Sid blood group system is a blood group system recognized by the International Society of Blood Transfusion (ISBT). It is one of the 36 human blood group systems currently identified by the ISBT. The Sid blood group system was named after the first identified antibody, anti-Sid, which was discovered in 2002.

History[edit]

The Sid blood group system was discovered in 2002 when a new antibody, anti-Sid, was identified in the serum of a woman who had been transfused multiple times. The antibody was named Sid after the patient's initials. The discovery of this new blood group system has expanded our understanding of human blood and its compatibility for blood transfusion.

Characteristics[edit]

The Sid blood group system is characterized by the presence or absence of the Sid antigen on the surface of red blood cells. Individuals who have the Sid antigen are classified as Sid positive, while those who lack the antigen are classified as Sid negative. The Sid antigen is a protein that is encoded by the SID gene.

Clinical significance[edit]

The clinical significance of the Sid blood group system lies in its potential to cause hemolytic disease of the newborn (HDN) and hemolytic transfusion reaction (HTR). If a Sid negative individual is transfused with Sid positive blood, the recipient's immune system may produce anti-Sid antibodies, leading to a hemolytic transfusion reaction. Similarly, if a Sid negative woman is pregnant with a Sid positive fetus, the mother's immune system may produce anti-Sid antibodies, potentially leading to hemolytic disease of the newborn.

Testing[edit]

Testing for the Sid blood group system is performed using serological methods. The presence or absence of the Sid antigen is determined by testing the patient's red blood cells with anti-Sid serum. If the red blood cells agglutinate, the patient is considered Sid positive. If no agglutination occurs, the patient is considered Sid negative.

See also[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Sid_blood_group_system&oldid=5337983"